As a centralized mail order source for their medication and supplies, BLN becomes a vital link to your patients with diabetes, which enables us to provide the additional support and value added services your organization needs to meet the demands of managing your patients. BLN's Diabetes Disease Management Support Program offers the managed care payer the tools they need to better manage and reduce the overall costs of providing diabetes care while 1) further reducing the costs of their medication and supplies, and 2) increasing patient compliance with their prescribed regimens which produces patient health outcomes which are more favorable to your bottom line. Our programs concentrate on the following components of patient care:
|
- Disease Management
- Patient Education and Self Care
- Counseling and Intervention
- Clinical Pharmacy Monitoring and Supply
- Medical Supply Fulfillment Services
- Data Collection and Reporting
|
BLN programs can be implemented in coordination with your internal disease management programs or can be administered as a "carve out" diabetes disease management program. Some additional highlights of our program are:
|
- Our products will have BLN preferred pricing
- BLN staff will process and monitor all orders for supplies and medication
- BLN staff will track patient compliance through a failure to reorder report with patient notification as necessary
- BLN will make regular contact with your patients regarding compliance with their prescribed regimens
- Your Case Managers will be notified monthly of all non-compliance
|
Insulin Pump Therapy Program
Tighter blood glucose control can literally change the course of your patient's lives. The ten-year DCCT (Diabetes Control and Complications Trial) showed that "Intensive Therapy" reduced eye, nerve, or kidney disease complications by 50% to 76%. In cases where a patient with diabetes has consistent problems maintaining their blood glucose level to a degree where their medical expenses run excessive due to emergency room visits, doctor visits, etc. and their HbA1c level is high; insulin pump therapy can make a lot of sense. Our insulin pump programs include training of the patient on the use of the pump and follow up support.
Asthma and Respiratory
In the United States asthma affects 14.6 billion people. It is the most common childhood chronic disease, affecting approximately 4.8 million children. This disease can start in infancy, childhood or adulthood. The prevalence and the mortality of asthma have both increased over the last two decades. Also, there is an overall increase in asthma severity, with an increase in death.
Following the BLN program of integrating patient education and support with the patient's medication and medical supplies fulfillment, health plans can achieve both short-term and long-term cost savings, while establishing a foundation for effective disease management.
Order Summary
View Cart
